1	Peripheral	peripheral	_	_	_	_	_	_	_
2	blood	blood	_	_	_	_	_	_	_
3	mononuclear	mononuclear	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	isolated	isolate	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	patients	patient	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	diabetic	diabetic	_	_	_	_	_	_	_
10	nephropathy	nephropathy	_	_	_	_	_	_	_
11	show	show	_	_	_	_	_	_	_
12	increased	increase	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	oxidative-stress	oxidative-stress	_	_	_	_	_	_	_
17	sensitive	sensitive	_	_	_	_	_	_	_
18	transcription	transcription	_	_	_	_	_	_	_
19	factor	factor	_	_	_	_	_	_	_
20	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Increased	increase	_	_	_	_	_	_	_
2	oxidative	oxidative	_	_	_	_	_	_	_
3	stress	stress	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	subsequent	subsequent	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
12	has	have	_	_	_	_	_	_	_
13	been	be	_	_	_	_	_	_	_
14	linked	link	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	development	development	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	late	late	_	_	_	_	_	_	_
20	diabetic	diabetic	_	_	_	_	_	_	_
21	complications	complication	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	determine	determine	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	oxidative	oxidative	_	_	_	_	_	_	_
5	stress	stress	_	_	_	_	_	_	_
6	dependent	dependent	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	evident	evident	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	patients	patient	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	diabetic	diabetic	_	_	_	_	_	_	_
15	nephropathy	nephropathy	_	_	_	_	_	_	_
16	we	we	_	_	_	_	_	_	_
17	used	use	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
20	Mobility	Mobility	_	_	_	_	_	_	_
21	Shift	Shift	_	_	_	_	_	_	_
22	Assay	Assay	_	_	_	_	_	_	_
23	based	based	_	_	_	_	_	_	_
24	semiquantitative	semiquantitative	_	_	_	_	_	_	_
25	detection	detection	_	_	_	_	_	_	_
26	system	system	_	_	_	_	_	_	_
27	which	which	_	_	_	_	_	_	_
28	enabled	enable	_	_	_	_	_	_	_
29	us	us	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	determine	determine	_	_	_	_	_	_	_
32	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
33	activation	activation	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	ex	ex	_	_	_	_	_	_	_
36	vivo	vivo	_	_	_	_	_	_	_
37	isolated	isolate	_	_	_	_	_	_	_
38	peripheral	peripheral	_	_	_	_	_	_	_
39	blood	blood	_	_	_	_	_	_	_
40	mononuclear	mononuclear	_	_	_	_	_	_	_
41	cells	cell	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	examined	examine	_	_	_	_	_	_	_
3	33	33	_	_	_	_	_	_	_
4	patients	patient	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	diabetes	diabetes	_	_	_	_	_	_	_
7	mellitus	mellitus	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	Type	type	_	_	_	_	_	_	_
10	I	i	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	Type	Type	_	_	_	_	_	_	_
13	II	ii	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Patients	patient	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	diabetic	diabetic	_	_	_	_	_	_	_
4	nephropathy	nephropathy	_	_	_	_	_	_	_
5	showed	show	_	_	_	_	_	_	_
6	higher	high	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	binding	binding	_	_	_	_	_	_	_
9	activity	activity	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
12	Mobility	Mobility	_	_	_	_	_	_	_
13	Shift	Shift	_	_	_	_	_	_	_
14	Assays	Assay	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	stronger	strong	_	_	_	_	_	_	_
17	immunohistological	immunohistological	_	_	_	_	_	_	_
18	staining	staining	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	activated	activate	_	_	_	_	_	_	_
21	NF-kappaBp65	nf-kappabp65	_	_	_	_	_	_	_
22	than	than	_	_	_	_	_	_	_
23	patients	patient	_	_	_	_	_	_	_
24	without	without	_	_	_	_	_	_	_
25	renal	renal	_	_	_	_	_	_	_
26	complications	complication	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	activity	activity	_	_	_	_	_	_	_
4	correlated	correlate	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	degree	degree	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	albuminuria	albuminuria	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	r	r	_	_	_	_	_	_	_
12	=	=	_	_	_	_	_	_	_
13	0.316	0.316	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	thrombomodulin	thrombomodulin	_	_	_	_	_	_	_
18	plasma	plasma	_	_	_	_	_	_	_
19	concentrations	concentration	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	r	r	_	_	_	_	_	_	_
22	=	=	_	_	_	_	_	_	_
23	0.33	0.33	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	indicative	indicative	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	albuminuria	albuminuria	_	_	_	_	_	_	_
29	associated	associated	_	_	_	_	_	_	_
30	endothelial	endothelial	_	_	_	_	_	_	_
31	dysfunction	dysfunction	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	3	3	_	_	_	_	_	_	_
4	day	day	_	_	_	_	_	_	_
5	intervention	intervention	_	_	_	_	_	_	_
6	study	study	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	which	which	_	_	_	_	_	_	_
9	600	600	_	_	_	_	_	_	_
10	mg	mg	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	antioxidant	antioxidant	_	_	_	_	_	_	_
14	thioctic	thioctic	_	_	_	_	_	_	_
15	acid	acid	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	alpha-lipoic	alpha-lipoic	_	_	_	_	_	_	_
18	acid	acid	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	per	per	_	_	_	_	_	_	_
21	day	day	_	_	_	_	_	_	_
22	were	be	_	_	_	_	_	_	_
23	given	give	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	nine	nine	_	_	_	_	_	_	_
26	patients	patient	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	diabetic	diabetic	_	_	_	_	_	_	_
29	nephropathy	nephropathy	_	_	_	_	_	_	_
30	oxidative	oxidative	_	_	_	_	_	_	_
31	stress	stress	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	plasma	plasma	_	_	_	_	_	_	_
34	samples	sample	_	_	_	_	_	_	_
35	was	be	_	_	_	_	_	_	_
36	decreased	decrease	_	_	_	_	_	_	_
37	by	by	_	_	_	_	_	_	_
38	48	48	_	_	_	_	_	_	_
39	%	%	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
42	binding	binding	_	_	_	_	_	_	_
43	activity	activity	_	_	_	_	_	_	_
44	in	in	_	_	_	_	_	_	_
45	ex	ex	_	_	_	_	_	_	_
46	vivo	vivo	_	_	_	_	_	_	_
47	isolated	isolate	_	_	_	_	_	_	_
48	peripheral	peripheral	_	_	_	_	_	_	_
49	blood	blood	_	_	_	_	_	_	_
50	mononuclear	mononuclear	_	_	_	_	_	_	_
51	cells	cell	_	_	_	_	_	_	_
52	by	by	_	_	_	_	_	_	_
53	38	38	_	_	_	_	_	_	_
54	%	%	_	_	_	_	_	_	_
55	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	conclusion	conclusion	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	activation	activation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	transcription	transcription	_	_	_	_	_	_	_
8	factor	factor	_	_	_	_	_	_	_
9	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	ex	ex	_	_	_	_	_	_	_
12	vivo	vivo	_	_	_	_	_	_	_
13	isolated	isolate	_	_	_	_	_	_	_
14	peripheral	peripheral	_	_	_	_	_	_	_
15	blood	blood	_	_	_	_	_	_	_
16	mononuclear	mononuclear	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	patients	patient	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	diabetes	diabetes	_	_	_	_	_	_	_
22	mellitus	mellitus	_	_	_	_	_	_	_
23	correlates	correlate	_	_	_	_	_	_	_
24	with	with	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	degree	degree	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	diabetic	diabetic	_	_	_	_	_	_	_
29	nephropathy	nephropathy	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	at	at	_	_	_	_	_	_	_
5	least	least	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	part	part	_	_	_	_	_	_	_
8	dependent	dependent	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	oxidative	oxidative	_	_	_	_	_	_	_
11	stress	stress	_	_	_	_	_	_	_
12	since	since	_	_	_	_	_	_	_
13	thioctic	thioctic	_	_	_	_	_	_	_
14	acid	acid	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	alpha-lipoic	alpha-lipoic	_	_	_	_	_	_	_
17	acid	acid	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	reduced	reduce	_	_	_	_	_	_	_
20	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
21	binding	binding	_	_	_	_	_	_	_
22	activity	activity	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

